Plum Street Advisors’s Idexx Laboratories IDXX Stock Holding History

Plum Street Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-482	Closed	-$326K	–	100
2025 Q4	$326K	Hold	482	–	–	0.12%	84
2025 Q3	$308K	Hold	482	–	–	0.12%	85
2025 Q2	$259K	Hold	482	–	–	0.11%	80
2025 Q1	$202K	Buy	+482	New	+$209K	0.1%	83
2024 Q4	–	Sell	-1,315	Closed	-$664K	–	85
2024 Q3	$664K	Buy	+1,315	New	+$639K	0.34%	51
2024 Q2	–	Sell	-1,315	Closed	-$664K	–	75
2024 Q1	$664K	Buy	+1,315	New	+$719K	0.34%	51

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Plum Street Advisors's IDXX Position: Q1 2026 in Review

Plum Street Advisors sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 482 shares — an estimated $326K sold.

Plum Street Advisors first reported a position in IDXX in Q1 2024 and held it in 6 quarters. The position peaked at $664K in Q3 2024. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Plum Street Advisors reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Plum Street Advisors sold 482 Idexx Laboratories shares in Q1 2026, an estimated $326K.
Plum Street Advisors first reported a position in Idexx Laboratories in Q1 2024 and held it in 6 quarters.
Plum Street Advisors's Idexx Laboratories position peaked at $664K in Q3 2024.
1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Plum Street Advisors's 13F filing for Q1 2026, filed 14 May 2026.